The ferry Yacaaba, skippered by George Lambourne. Photo: Supplied by John Clarke. The Simplex, owned and worked by the ...
The novel oral helicase-primase inhibitor offers a non-intravenous option for immunocompromised adults with mucocutaneous HSV refractory to standard antivirals.
A new PLOS Pathogens study shows that the interferon-induced GTPase GBP7 unexpectedly promotes HSV-1 infection by activating ...
FDA approves Hovilpri (pritelivir) for herpes lesions resistant to acyclovir, valacyclovir, or famciclovir in ...
The regulatory decision followed findings from PRIOH-1 Part C, an open-label, comparator-controlled Phase III superiority ...
The Sensex edged lower by 0.03% on 14 Oct 2026, while Simplex Infrastructures Ltd surged 8.04%, touching an intraday high of ...
The US Food and Drug Administration (FDA) approved Hovilpri (pritelivir) tablets for adults with weakened immune systems (i.e ...
Herpes Awareness Day takes place annually on Oct. 13. The day promotes awareness and aims to end the stigma surrounding the herpes simplex virus, commonly known as herpes.
The FDA approved Hovilpri for herpes lesions that do not respond to other antivirals in immunocompromised adults. In a trial, 63% achieved complete healing.
Oct 9 (Reuters) - The US FDA on Friday approved Japan's Asahi Kasei's drug for persistent herpes simplex virus sores in ...
Simplex Castings issued a corrigendum to correct allottee names in its EGM notice. Promoter Ketan Moolchand Shah's stake will ...
The FDA has approved pritelivir to treat mucocutaneous lesions caused by herpes simplex virus in immunocompromised adult ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results